A-shares plunged over the past week. Harbin Pharmaceutical became the top-performing stock with a weekly gain of 58.16%, while Meixin Technology led the decline with a drop of 41.12%. Harbin Pharmaceutical disclosed on July 9 that its attributable net profit for the first half of 2026 is expected to increase by 46.40% to 68.36%, and that 118 of its product specifications have been included in the new edition of the National Essential Medicines List. The stock hit consecutive daily limit-up moves, but the limit was broken on July 17, closing up 7.89%. Meixin Technology saw profit-taking after its share price hit a record high, plunging over 41% for the week. Despite revenue growth in the first quarter, net profit fell 33.32% year-on-year. Coupled with a broad sell-off in tech stocks, the share price underwent a sharp correction. All ten stocks on this week's bear list posted weekly declines exceeding 39%, mostly due to concentrated capital outflows after prior highs.
Harbin Pharmaceutical Group Co Ltd118 product specifications included in new National Essential Medicines List, boosting demand outlook.
Xian Xice Testing Technology Co. Ltd. ANet profit fell 33.32% year-on-year despite revenue growth.
Misun Technology Co LtdNot mentioned in article; only listed as index entry.